Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LETIbalm is a specialized topical repair skincare line developed by LETI Pharma (Laboratorios LETI). It is formulated as an over-the-counter (OTC) cosmetic product designed to restore and repair the skin barrier. The product range includes balms, fluids, sticks, and body formulations specifically targeted at dry, chapped, and irritated skin, particularly on the nose and lips. Its mechanism of action involves emollient, moisturizing, and protective effects mediated by a combination of barrier-restoring ingredients such as ceramides (Ceramide NP, Ceramide AP, Ceramide EOP), shea butter, niacinamide, squalane, and allantoin. Clinical studies have demonstrated its efficacy in extreme conditions (e.g., for athletes) and in patients undergoing isotretinoin treatment for acne.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LETIbalm.